Convalescent Plasma Therapy Global Market Report 2024

Description

“Convalescent Plasma Therapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on convalescent plasma therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for convalescent plasma therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The convalescent plasma therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Antibody type: IgM; IgG; IgA
2) By Application: Prophylaxis; Treatment
3) By End-Users: Hospitals & Clinics; Laboratories & Research institutes
Companies Mentioned: Bio Farma; Hilton Pharma Ltd.; Biotest AG; BPL Ltd.; LFB SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Convalescent plasma refers to plasma obtained from individuals who have recuperated from an infection and contains antibodies targeting the specific microorganism responsible for the infection. It is employed in the treatment of patients afflicted by the same pathogen.

The principal antibody categories utilized in convalescent plasma therapy are Immunoglobulin M (IgM), Immunoglobulin G (IgG), and Immunoglobulin A (IgA). Immunoglobulin A (IgA) is a crucial antibody for immune activities within mucous membranes. Convalescent plasma finds various applications, including preventive measures (prophylaxis) and treatment, and is applied across a range of sectors, including hospitals, clinics, laboratories, and research institutes.

The convalescent plasma therapy market research report is one of a series of new reports from The Business Research Company that provides convalescent plasma therapy market statistics, including convalescent plasma therapy industry global market size, regional shares, competitors with a convalescent plasma therapy market share, detailed convalescent plasma therapy market segments, market trends and opportunities, and any further data you may need to thrive in the convalescent plasma therapy industry. This convalescent plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The convalescent plasma therapy market size has grown rapidly in recent years. It will grow from $0.05 billion in 2023 to $0.05 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth observed in the historical period can be attributed to factors such as pandemics and outbreaks of infectious diseases, ongoing research in immunotherapy, the granting of emergency use authorizations (EUA), the availability of patients for treatment, and increased awareness among clinicians and the general public.

The convalescent plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.08 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%. The anticipated growth in the forecast period can be attributed to several key factors, including the evolution of pathogens, advancements in the development of immunotherapies, the establishment of regulatory frameworks, enhanced global preparedness, and the implementation of public health initiatives. Notable trends expected during this forecast period encompass the adoption of standardized collection and processing procedures, the focus on targeted plasma components, personalized treatment approaches, the integration of telemedicine and remote monitoring, and continued research into the long-term effects of treatments.

The growth of the convalescent plasma therapy market can be attributed to the higher efficacy and safety observed during trials conducted in COVID-19 patients. Convalescent plasma transfusion, historically used for treating infectious diseases such as SARS-1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1, has gained attention. For example, a study by the Houston Methodist hospital in June 2020 found that COVID-19 convalescent plasma therapy was safe, with no adverse events reported, and efficient, leading to a 76% recovery rate. Another study published in May 2020 in the Journal of Medical Virology suggested that convalescent plasma therapy could reduce the mortality rate in critically ill patients, improve clinical symptoms, increase neutralizing antibody titers, and eliminate SARS-CoV-2 RNA. The safety and efficacy of convalescent plasma therapy are expected to drive the global market's growth.

The increase in the number of hospitals is expected to propel the growth of the convalescent plasma therapy market. Hospitals are dedicated medical facilities providing a wide range of healthcare services, including diagnosis, treatment, and patient care. The rise in the number of hospitals often indicates improved healthcare infrastructure, offering better facilities for collecting, processing, and administering convalescent plasma. For instance, a report by Public Health Scotland in September 2022 indicated an increase in staffed beds for acute specialties, reaching an average of 13,323 in 2021/22, a 3.6% increase from the previous year (2020/21). Increased occupancy rates from 74.8% in 2020-21 to 84.2% in 2021/22 signify the growth in healthcare facilities. Therefore, the surge in hospital numbers is a key driver of the convalescent plasma therapy market.

Despite its potential, the convalescent plasma therapy market faces challenges due to the limited evidence regarding safety and efficacy, leading to strict guidelines imposed by government authorities. Different government bodies like the US FDA and India's CDSCO have approved COVID-19 convalescent plasma for investigational use only and not as a prescribed treatment. FDA guidelines from May 2020 state that convalescent plasma administration should be done under an investigational new drug application (IND) for clinical trials, expanded access, or single-patient emergency use. These stringent guidelines are expected to limit market growth.

The development of antibody-based immunotherapy for COVID-19 presents opportunities for the convalescent plasma therapy market. This therapy, which utilizes antibodies to enhance a patient's immunity, has garnered attention from companies investing in antibody-based COVID-19 treatments. For example, Regeneron Pharmaceuticals Inc. collaborated with the Biomedical Advanced Research and Development Authority (BARDA) to develop next-generation COVID-19 monoclonal antibody therapy. This focus on antibody-based COVID-19 therapy is likely to boost the convalescent plasma therapy market.

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America's Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

North America was the largest region in the convalescent plasma therapy market in 2023. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the convalescent plasma therapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The convalescent plasma therapy market includes revenue earned by IgD and IgE. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r9094

1. Executive Summary

2. Convalescent Plasma Therapy Market Characteristics

3. Convalescent Plasma Therapy Market Trends And Strategies

4. Convalescent Plasma Therapy Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Convalescent Plasma Therapy Market Size and Growth

5.1. Global Convalescent Plasma Therapy Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Convalescent Plasma Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Convalescent Plasma Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Convalescent Plasma Therapy Market Segmentation

6.1. Global Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Immunoglobulin M (IgM)
Immunoglobulin G (IgG)
Immunoglobulin A
6.2. Global Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prophylaxis
Treatment
6.3. Global Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Laboratories And Research Institutes

7. Convalescent Plasma Therapy Market Regional And Country Analysis

7.1. Global Convalescent Plasma Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Convalescent Plasma Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Convalescent Plasma Therapy Market

8.1. Asia-Pacific Convalescent Plasma Therapy Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Convalescent Plasma Therapy Market

9.1. China Convalescent Plasma Therapy Market Overview
9.2. China Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Convalescent Plasma Therapy Market

10.1. India Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Convalescent Plasma Therapy Market

11.1. Japan Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Convalescent Plasma Therapy Market

12.1. Australia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Convalescent Plasma Therapy Market

13.1. Indonesia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Convalescent Plasma Therapy Market

14.1. South Korea Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Convalescent Plasma Therapy Market

15.1. Western Europe Convalescent Plasma Therapy Market Overview
15.2. Western Europe Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Convalescent Plasma Therapy Market

16.1. UK Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Convalescent Plasma Therapy Market

17.1. Germany Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Convalescent Plasma Therapy Market

18.5. France Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Convalescent Plasma Therapy Market

19.9. Italy Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Convalescent Plasma Therapy Market

20.13. Spain Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Convalescent Plasma Therapy Market

21.1. Eastern Europe Convalescent Plasma Therapy Market Overview
21.2. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Convalescent Plasma Therapy Market

22.1. Russia Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Convalescent Plasma Therapy Market

23.1. North America Convalescent Plasma Therapy Market Overview
23.2. North America Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Convalescent Plasma Therapy Market

24.1. USA Convalescent Plasma Therapy Market Overview
24.2. USA Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Convalescent Plasma Therapy Market

25.1. Canada Convalescent Plasma Therapy Market Overview
25.2. Canada Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Convalescent Plasma Therapy Market

26.1. South America Convalescent Plasma Therapy Market Overview
26.2. South America Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Convalescent Plasma Therapy Market

27.1. Brazil Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Convalescent Plasma Therapy Market

28.1. Middle East Convalescent Plasma Therapy Market Overview
28.2. Middle East Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Convalescent Plasma Therapy Market

29.1. Africa Convalescent Plasma Therapy Market Overview
29.2. Africa Convalescent Plasma Therapy Market, Segmentation By Antibody Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Convalescent Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Convalescent Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Convalescent Plasma Therapy Market Competitive Landscape And Company Profiles

30.1. Convalescent Plasma Therapy Market Competitive Landscape
30.2. Convalescent Plasma Therapy Market Company Profiles
- 30.2.1. Bio Farma
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Hilton Pharma Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Biotest AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. BPL Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. LFB SA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Convalescent Plasma Therapy Market Competitive Benchmarking

32. Global Convalescent Plasma Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Convalescent Plasma Therapy Market

34. Convalescent Plasma Therapy Market Future Outlook and Potential Analysis

34.1 Convalescent Plasma Therapy Market In 2028 - Countries Offering Most New Opportunities
34.2 Convalescent Plasma Therapy Market In 2028 - Segments Offering Most New Opportunities
34.3 Convalescent Plasma Therapy Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer